• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型的泌尿道分化、组织再生和疾病模型:将人类前列腺和膀胱细胞重编程为诱导多能干细胞。

A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells.

作者信息

Moad Mohammad, Pal Deepali, Hepburn Anastasia C, Williamson Stuart C, Wilson Laura, Lako Majlinda, Armstrong Lyle, Hayward Simon W, Franco Omar E, Cates Justin M, Fordham Sarah E, Przyborski Stefan, Carr-Wilkinson Jane, Robson Craig N, Heer Rakesh

机构信息

Northern Institute for Cancer Research, Newcastle University, UK.

出版信息

Eur Urol. 2013 Nov;64(5):753-61. doi: 10.1016/j.eururo.2013.03.054. Epub 2013 Apr 6.

DOI:10.1016/j.eururo.2013.03.054
PMID:23582880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3819995/
Abstract

BACKGROUND

Primary culture and animal and cell-line models of prostate and bladder development have limitations in describing human biology, and novel strategies that describe the full spectrum of differentiation from foetal through to ageing tissue are required. Recent advances in biology demonstrate that direct reprogramming of somatic cells into pluripotent embryonic stem cell (ESC)-like cells is possible. These cells, termed induced pluripotent stem cells (iPSCs), could theoretically generate adult prostate and bladder tissue, providing an alternative strategy to study differentiation.

OBJECTIVE

To generate human iPSCs derived from normal, ageing, human prostate (Pro-iPSC), and urinary tract (UT-iPSC) tissue and to assess their capacity for lineage-directed differentiation.

DESIGN, SETTING, AND PARTICIPANTS: Prostate and urinary tract stroma were transduced with POU class 5 homeobox 1 (POU5F1; formerly OCT4), SRY (sex determining region Y)-box 2 (SOX2), Kruppel-like factor 4 (gut) (KLF4), and v-myc myelocytomatosis viral oncogene homolog (avian) (MYC, formerly C-MYC) genes to generate iPSCs.

OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS

The potential for differentiation into prostate and bladder lineages was compared with classical skin-derived iPSCs. The student t test was used.

RESULTS AND LIMITATIONS

Successful reprogramming of prostate tissue into Pro-iPSCs and bladder and ureter into UT-iPSCs was demonstrated by characteristic ESC morphology, marker expression, and functional pluripotency in generating all three germ-layer lineages. In contrast to conventional skin-derived iPSCs, Pro-iPSCs showed a vastly increased ability to generate prostate epithelial-specific differentiation, as characterised by androgen receptor and prostate-specific antigen induction. Similarly, UT-iPSCs were shown to be more efficient than skin-derived iPSCs in undergoing bladder differentiation as demonstrated by expression of urothelial-specific markers: uroplakins, claudins, and cytokeratin; and stromal smooth muscle markers: α-smooth-muscle actin, calponin, and desmin. These disparities are likely to represent epigenetic differences between individual iPSC lines and highlight the importance of organ-specific iPSCs for tissue-specific studies.

CONCLUSIONS

IPSCs provide an exciting new model to characterise mechanisms regulating prostate and bladder differentiation and to develop novel approaches to disease modelling. Regeneration of bladder cells also provides an exceptional opportunity for translational tissue engineering.

摘要

背景

前列腺和膀胱发育的原代培养以及动物和细胞系模型在描述人类生物学方面存在局限性,因此需要能够描述从胎儿到衰老组织全部分化谱的新策略。生物学领域的最新进展表明,将体细胞直接重编程为多能胚胎干细胞(ESC)样细胞是可行的。这些细胞被称为诱导多能干细胞(iPSC),理论上可以生成成人前列腺和膀胱组织,为研究分化提供了一种替代策略。

目的

从正常、衰老的人类前列腺(Pro-iPSC)和泌尿道(UT-iPSC)组织中生成人类iPSC,并评估其定向分化的能力。

设计、设置和参与者:用POU5类同源盒1(POU5F1;原称OCT4)、SRY(性别决定区Y)盒2(SOX2)、Kruppel样因子4(肠道)(KLF4)和v-myc髓细胞瘤病毒癌基因同源物(禽类)(MYC,原称C-MYC)基因转导前列腺和泌尿道基质以生成iPSC。

结果测量和统计分析

将向前列腺和膀胱谱系分化的潜力与经典的皮肤来源iPSC进行比较。使用学生t检验。

结果和局限性

通过特征性的ESC形态、标志物表达以及生成所有三个胚层谱系的功能多能性,证明了前列腺组织成功重编程为Pro-iPSC,膀胱和输尿管成功重编程为UT-iPSC。与传统的皮肤来源iPSC相比,Pro-iPSC表现出极大增强的生成前列腺上皮特异性分化的能力,其特征为雄激素受体和前列腺特异性抗原的诱导。同样,UT-iPSC在经历膀胱分化方面比皮肤来源iPSC更有效,这通过尿路上皮特异性标志物:尿板蛋白、紧密连接蛋白和细胞角蛋白的表达;以及基质平滑肌标志物:α-平滑肌肌动蛋白、钙调蛋白和结蛋白得以证明。这些差异可能代表了各个iPSC系之间的表观遗传差异,并突出了器官特异性iPSC在组织特异性研究中的重要性。

结论

iPSC为表征调节前列腺和膀胱分化的机制以及开发疾病建模的新方法提供了一个令人兴奋的新模型。膀胱细胞的再生也为转化组织工程提供了一个绝佳的机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c06f/3819995/1e482611ee3a/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c06f/3819995/d95250a9e143/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c06f/3819995/ee936b4b7015/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c06f/3819995/1ab556f5a311/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c06f/3819995/12a87f2396ce/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c06f/3819995/1e482611ee3a/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c06f/3819995/d95250a9e143/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c06f/3819995/ee936b4b7015/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c06f/3819995/1ab556f5a311/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c06f/3819995/12a87f2396ce/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c06f/3819995/1e482611ee3a/gr5.jpg

相似文献

1
A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells.一种新型的泌尿道分化、组织再生和疾病模型:将人类前列腺和膀胱细胞重编程为诱导多能干细胞。
Eur Urol. 2013 Nov;64(5):753-61. doi: 10.1016/j.eururo.2013.03.054. Epub 2013 Apr 6.
2
Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells.将人类原始生殖细胞直接重编程为诱导多能干细胞:高效生成基因工程化生殖细胞。
Stem Cells Dev. 2015 Nov 15;24(22):2634-48. doi: 10.1089/scd.2015.0100. Epub 2015 Aug 10.
3
Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34 cells using the auto-erasable Sendai virus vector.使用可自动清除的 Sendai 病毒载体,从患者非动员外周血源性 CD34 细胞中高效生成稳健的 hiPSC。
Stem Cell Res Ther. 2019 Jun 24;10(1):185. doi: 10.1186/s13287-019-1273-2.
4
Inducing Pluripotency in the Domestic Cat ().诱导家猫的多能性()。
Stem Cells Dev. 2019 Oct 1;28(19):1299-1309. doi: 10.1089/scd.2019.0142. Epub 2019 Sep 5.
5
NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction.NKX3-1 对于诱导多能干细胞重编程是必需的,并且可以在小鼠和人诱导多能干细胞的诱导中替代 OCT4。
Nat Cell Biol. 2018 Aug;20(8):900-908. doi: 10.1038/s41556-018-0136-x. Epub 2018 Jul 16.
6
Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.在没有 c-Myc 的情况下重编程诱导多能干细胞分化为肝细胞样细胞。
Biomaterials. 2011 Sep;32(26):5994-6005. doi: 10.1016/j.biomaterials.2011.05.009. Epub 2011 Jun 11.
7
Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.通过MYC反式激活结构域与OCT4融合提高人类体细胞重编程效率
Stem Cell Res. 2017 Dec;25:88-97. doi: 10.1016/j.scr.2017.10.014. Epub 2017 Oct 26.
8
c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.c-MYC 非依赖性核重编程有利于诱导多能干细胞的心脏生成潜能。
J Cardiovasc Transl Res. 2010 Feb;3(1):13-23. doi: 10.1007/s12265-009-9150-5.
9
Reprogramming bladder cancer cells for studying cancer initiation and progression.对膀胱癌细胞进行重编程以研究癌症的起始和进展。
Tumour Biol. 2016 Oct;37(10):13237-13245. doi: 10.1007/s13277-016-5226-4. Epub 2016 Jul 25.
10
Zinc finger nuclease-expressing baculoviral vectors mediate targeted genome integration of reprogramming factor genes to facilitate the generation of human induced pluripotent stem cells.锌指核酸酶表达杆状病毒载体介导重编程因子基因的靶向基因组整合,以促进人类诱导多能干细胞的产生。
Stem Cells Transl Med. 2013 Dec;2(12):935-45. doi: 10.5966/sctm.2013-0043. Epub 2013 Oct 28.

引用本文的文献

1
Differentiation of human pluripotent stem cells into urothelial organoids via transient activation of WNT signaling.通过短暂激活WNT信号通路将人类多能干细胞分化为尿路上皮类器官
iScience. 2025 Apr 10;28(5):112398. doi: 10.1016/j.isci.2025.112398. eCollection 2025 May 16.
2
Bioprinted research models of urological malignancy.泌尿外科恶性肿瘤的生物打印研究模型
Exploration (Beijing). 2024 Feb 20;4(4):20230126. doi: 10.1002/EXP.20230126. eCollection 2024 Aug.
3
KLF4 Induces Colorectal Cancer by Promoting EMT via STAT3 Activation.

本文引用的文献

1
Human α(2)β(1)(HI) CD133(+VE) epithelial prostate stem cells express low levels of active androgen receptor.人α(2)β(1)(HI) CD133(+)上皮前列腺干细胞表达低水平的活性雄激素受体。
PLoS One. 2012;7(11):e48944. doi: 10.1371/journal.pone.0048944. Epub 2012 Nov 7.
2
Multipotent and unipotent progenitors contribute to prostate postnatal development.多能祖细胞和单能祖细胞共同促进前列腺的出生后发育。
Nat Cell Biol. 2012 Nov;14(11):1131-8. doi: 10.1038/ncb2600. Epub 2012 Oct 14.
3
The promise of induced pluripotent stem cells in research and therapy.
KLF4 通过激活 STAT3 促进 EMT 诱导结直肠癌。
Dig Dis Sci. 2024 Aug;69(8):2841-2855. doi: 10.1007/s10620-024-08473-y. Epub 2024 May 30.
4
The use of artificial intelligence in induced pluripotent stem cell-based technology over 10-year period: A systematic scoping review.在诱导多能干细胞技术中使用人工智能的 10 年历程:系统范围综述。
PLoS One. 2024 May 21;19(5):e0302537. doi: 10.1371/journal.pone.0302537. eCollection 2024.
5
Organoids: An Emerging Precision Medicine Model for Prostate Cancer Research.类器官:前列腺癌研究中的新兴精准医学模型。
Int J Mol Sci. 2024 Jan 16;25(2):1093. doi: 10.3390/ijms25021093.
6
Cellular models in autoinflammatory disease research.自身炎症性疾病研究中的细胞模型。
Clin Transl Immunology. 2024 Jan 11;13(1):e1481. doi: 10.1002/cti2.1481. eCollection 2024.
7
Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy.探索诱导多能干细胞在癌症研究和治疗中的广阔前景。
Mol Cancer. 2023 Nov 28;22(1):189. doi: 10.1186/s12943-023-01873-0.
8
AZGP1P2/UBA1/RBM15 Cascade Mediates the Fate Determinations of Prostate Cancer Stem Cells and Promotes Therapeutic Effect of Docetaxel in Castration-Resistant Prostate Cancer via TPM1 m6A Modification.AZGP1P2/UBA1/RBM15级联反应通过TPM1 m6A修饰介导前列腺癌干细胞的命运决定并增强多西他赛在去势抵抗性前列腺癌中的治疗效果。
Research (Wash D C). 2023 Oct 17;6:0252. doi: 10.34133/research.0252. eCollection 2023.
9
Engineering prostate cancer in vitro: what does it take?体外构建前列腺癌模型:需要做些什么?
Oncogene. 2023 Aug;42(32):2417-2427. doi: 10.1038/s41388-023-02776-6. Epub 2023 Jul 12.
10
Prostate organoids: emerging experimental tools for translational research.前列腺类器官:转化研究中的新兴实验工具。
J Clin Invest. 2023 May 15;133(10):e169616. doi: 10.1172/JCI169616.
诱导多能干细胞在研究和治疗中的应用前景。
Nature. 2012 Jan 18;481(7381):295-305. doi: 10.1038/nature10761.
4
Tissue engineering potential of urothelial cells from diseased bladders.病变膀胱尿路上皮细胞的组织工程潜力。
J Urol. 2011 Nov;186(5):2014-20. doi: 10.1016/j.juro.2011.07.031. Epub 2011 Sep 23.
5
In situ lineage tracking of human prostatic epithelial stem cell fate reveals a common clonal origin for basal and luminal cells.原位谱系追踪揭示了人前列腺上皮干细胞命运的一个共同克隆起源,即基底细胞和腔细胞。
J Pathol. 2011 Oct;225(2):181-8. doi: 10.1002/path.2965.
6
Chemically defined conditions for human iPSC derivation and culture.人诱导多能干细胞的化学定义条件及其培养。
Nat Methods. 2011 May;8(5):424-9. doi: 10.1038/nmeth.1593. Epub 2011 Apr 10.
7
Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells.人类诱导多能干细胞中异常表观基因组重编程的热点。
Nature. 2011 Mar 3;471(7336):68-73. doi: 10.1038/nature09798. Epub 2011 Feb 2.
8
Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.利用合成修饰 mRNA 高效重编程人类细胞为多能性干细胞并进行定向分化。
Cell Stem Cell. 2010 Nov 5;7(5):618-30. doi: 10.1016/j.stem.2010.08.012. Epub 2010 Sep 30.
9
Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells.细胞起源类型影响小鼠诱导多能干细胞的分子和功能特性。
Nat Biotechnol. 2010 Aug;28(8):848-55. doi: 10.1038/nbt.1667. Epub 2010 Jul 19.
10
Epigenetic memory in induced pluripotent stem cells.诱导多能干细胞中的表观遗传记忆。
Nature. 2010 Sep 16;467(7313):285-90. doi: 10.1038/nature09342.